iuga.news

Now Accepting Intents to Bid- IUGA Annual Meeting 2023

We are now requesting intents-to-bid for the IUGA Annual Meeting in 2023 which will take place in Europe. The intent-to-bid must be submitted in electronic form before/on May 25, 2019 to David Casalod, Executive Director at This email address is being protected from spambots. You need JavaScript enabled to view it. with a copy to Vivian Gies, Meeting Director at This email address is being protected from spambots. You need JavaScript enabled to view it..

For more information, click here.

New Version of NICE Guideline Released

The third version of the National Institute for Health and Clinical Excellence (NICE) guideline on the management of urinary incontinence and pelvic organ prolapse in women was released on 2 April 2019.

It includes pelvic organ prolapse for the first time, as the earlier two versions (2006 and 2013) only covered urinary incontinence. It advocates conservative measures before offering surgery and outlines local as well as regional multidisciplinary team meetings (MDT) for simple and complex cases. The guideline specifies national database documentation of surgery, including safety and effectiveness, and notification of mesh complications and also outlines the need for specialized centers for the assessment and management of mesh related complications.  

The guideline includes retropubic bottom up mid-urethral tape as an option for surgical management for stress incontinence of urine after colposuspension, autologous sling, and urethral bulking agents. The guideline included vaginal mesh for recurrent anterior compartment prolapse in women with adequate vault support in whom an abdominal approach is contra-indicated after proper counseling and discussion at a regional multidisciplinary team meeting (MDT). The guideline does not advocate prophylactic continence procedures at the time of prolapse surgery. While the guideline does not discourage performing continence procedures alongside surgery for anterior and apical compartment prolapse for patients with concomitant urodynamic stress incontinence of urine, it recommends adequate patient counseling about the uncertain benefit and potential for complications.

Read the Full Guideline

Abstract Submission Deadline Extended

DEADLINE EXTENDED: April 15, 2019
We understand how busy life can get, so we are giving you the weekend to finalize your submission! Don't miss out on your chance to present your work to an international audience of approximately 2,000 healthcare professionals working in the field of urogynecology!

Abstracts can be submitted for oral presentations, oral posters, video presentations, scientific salons and posters.

Categories include:
• Anatomy
• Anorectal Disorders
• Basic Science
• Conservative Management
• Education
• Epidemiology/Quality of Life
• Evaluation & Training
• Healthcare Delivery/Systems
• Public Health/Population Studies (not covered in Epidemiology)
• Sexual Function/Sexual Pain
• Surgical

For more information or to submit your abstract, click here

New Issue of IUJ Now Available

Don't miss out on the latest news and research in the international field of urogynecology! Click here to read the newest issue of IUJ!

Apply for an IUGA Observership Grant

Observational learning is a great way to enhance your skill set, but the opportunity to observe the best in the field can be expensive! That’s why we offer 3 IUGA Observership Grants to offset the costs of visiting a site with proven expertise in your expressed area of interest in urogynecology.

Observership grants help defray travel and living expenses during a 2-4 week observership at an IUGA-approved host site. Preparing your application and making arrangements with an approved host site (or getting a site approved) can take some time. Individuals interested in applying are therefore encouraged to start the application process early.

One observership will be awarded in each of the following categories:

  • $4,000 USD for a trainee, fellow, or physician-in-training
  • $4000 USD for a consultant from a Least Developed Country (low and lower-middle income countries as defined by the World Bank)
  • $2,000 for any IUGA member

Applications must be received by 11:59pm CDT on Friday, September 6, 2019.

LEARN MORE & APPLY

IUGA Research & Development Committee Supports Consensus Recommendations for Managing Genitourinary Syndrome of Menopause in Women With or at a High Risk for Breast Cancer

Genitourinary syndrome of menopause (GSM) is more prevalent in breast cancer survivors yet is often undiagnosed and untreated. The lack of safety evidence for vaginal hormone therapies in women with or at high risk for breast cancer often results in the lack of treatment, which can adversely affect quality of life and intimate relationships. A consensus panel of 16 experts from the North American Menopause Society and the International Society for the Study of Women’s Sexual Health therefore undertook an iterative process which included literature reviews, presentations, debate, and discussion of divergent opinions to develop consensus recommendations for clinicians. The recommendations were published in June (2018) in Menopause: The Journal of The North American Menopause Society.

The panel concluded that nonhormonal treatments are generally first-line therapies for treating GSM in women with or at high risk for breast cancer. The article provides recommendations for specific patient populations including women with a high risk for breast cancer, women with ER-positive breast cancers, women with triple-negative breast cancers, and women with metastatic disease.

Faubion S, Larkin L, Stuenkel C, Bachmann G et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer. Consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health. Menopause. 2018;25(6):596-608.

 

 

Registration Open for IUGA International Symposium on Birth Trauma and Pelvic Floor Health

We are excited to announce that registration for the IUGA International Symposium on Birth Trauma and Pelvic Floor Health for Allied Health Professionals is now open! This two-day symposium will take place June 29-30, 2019 at Croydon University Hospital in the UK.

After participating in this symposium, attendees will have a clear understanding of:

  • The different options, modalities, and opportunities to treat pelvic floor disorders
  • The importance of a multi-disciplinary approach to the treatment of pelvic floor disorders
  • How and when to assess the possibility of and who is at risk for pelvic floor trauma

For more information and to register, click here.

New CME Course Pelvic Floor Rehabilitation and March e-lecture!

We are always adding new videos, courses, and other educational opportunities to the IUGA Academy!

Have you seen the March e-lecture MIS surgery - How to avoid and recognize complications by Catherine Matthews?

We also have a new CME Course on Pelvic Floor Rehabiliation with presentations by Bary Berghmans, Hedwig Neels, Corlia Brandt, and Maura Seleme!

Check it out online or on the new IUGA Academy App!

 

Submit Your Abstract for AUGS/IUGA 2019 Joint Scientific Meeting

There is less than six weeks left to submit your abstract for consideration at the 2019 AUGS/IUGA Joint Scientific Meeting. Join more than 2,000 colleagues from around the world in Nashville!

Abstracts can be submitted for oral presentations, oral posters, video presentations, scientific salons and posters.

Categories include:
• Anatomy
• Anorectal Disorders
• Basic Science
• Conservative Management
• Education
• Epidemiology/Quality of Life
• Evaluation & Training
• Healthcare Delivery/Systems
• Public Health/Population Studies (not covered in Epidemiology)
• Sexual Function/Sexual Pain
• Surgical

The deadline is Aprill 12, so don't delay!

Click here for more information.